The angiotensin receptor blocker valsartan is as effective in reducing the risk of atherosclerotic events as captopril

By  

Inpharma, Vol. 1, Iss. 1531, 2006-01 ,pp. : 11-11

Adis International

Access to resources Recommend Favorite

Effects of a new endothelin receptor antagonist, TAK-044, on myocardial stunning in dogs

By Kitayoshi T.   Ikeda S.   Kubo K.   Awane-Igata Y.   Watanabe T.   Fujino M.  

European Journal of Pharmacology, Vol. 305, Iss. 1, 1996-06 ,pp. : 137-143

Elsevier

Access to resources Recommend Favorite

Antiproteinuric Effect of Angiotensin-converting Enzyme Inhibitors and an Angiotensin II Receptor Blocker in Patients with Lupus Nephritis

By Kitamura N   Matsukawa Y   Takei M   Sawada S  

The Journal of International Medical Research, Vol. 37, Iss. 3, 2009-05 ,pp. : 892-898

Field House Publishing

Access to resources Recommend Favorite

Angiotensin II Receptor Antagonist EXP 3174 Reduces Infarct Size Comparable with Enalaprilat and Augments Preconditioning in the Pig Heart

By Schwarz Ernst   Montino Holger   Fleischhauer Jan   Klues Heinrich   vom Dahl Jürgen   Hanrath Peter  

Cardiovascular Drugs and Therapy, Vol. 11, Iss. 5, 1997-11 ,pp. : 687-695

Springer Publishing Company

Access to resources Recommend Favorite

Omapatrilat Limits Infarct Size and Lowers the Threshold for Induction of Myocardial Preconditioning Through a Bradykinin Receptor-Mediated Mechanism

By Ebrahim Z.   Baxter G.F.   Yellon D.M.  

Cardiovascular Drugs and Therapy, Vol. 18, Iss. 2, 2004-03 ,pp. : 127-134

Springer Publishing Company

Access to resources Recommend Favorite